Page last updated: 2024-10-27

gabexate and Water-Electrolyte Imbalance

gabexate has been researched along with Water-Electrolyte Imbalance in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Water-Electrolyte Imbalance: Disturbances in the body's WATER-ELECTROLYTE BALANCE.

Research Excerpts

ExcerptRelevanceReference
"Sixty-one patients operated for esophageal cancer from 1996 to 2000 were treated postoperatively with low dose dopamine (300 microg/kg/h), gabexate mesilate (80 mg/h), and ulinastatin (300 000 unit/day) as a study group."1.33Use of low dose dopamine, gabexate mesilate and ulinastatin reduces the water balance and pulmonary complication in thoracic esophagectomy patients. ( Fujii, Y; Ishiguro, H; Kimura, M; Kuwabara, Y; Sato, A; Shinoda, N, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, A1
Kuwabara, Y1
Shinoda, N1
Kimura, M1
Ishiguro, H1
Fujii, Y1

Other Studies

1 other study available for gabexate and Water-Electrolyte Imbalance

ArticleYear
Use of low dose dopamine, gabexate mesilate and ulinastatin reduces the water balance and pulmonary complication in thoracic esophagectomy patients.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2005, Volume: 18, Issue:3

    Topics: Carcinoma, Squamous Cell; Dopamine; Esophageal Neoplasms; Esophagectomy; Gabexate; Glycoproteins; Hu

2005